No Effect of Continued Antiarrhythmic Drug Treatment on Top of Optimized Pulmonary Vein Isolation in Patients With Persistent Atrial Fibrillation: Results From the POWDER-AF2 Trial.
Anthony DemolderLouisa O'NeillMilad El HaddadDaniel ScherrJohan VijgenMichael WolfBenjamin BerteFelipe BisbalArne JohannessenMaximo Rivero-AyerzaTom J R De PotterBenjamin De BeckerJean-Benoît Le Polain de WarouxSebastian KnechtRene H TavernierMattias DuytschaeverPublished in: Circulation. Arrhythmia and electrophysiology (2023)
gov; Unique identifier: NCT03437356.